Novartis Venture Fund

We are stage agnostic (seed to commercial companies) and invest in multiple therapeutic areas where there is clear unmet medical need. Our first step in the process is to review non-confidential information about the company, team, technology / data, financial and exit plan. The further evaluation of business proposals is then based on confidential presentations by the management team that starts the full due diligence process.

Investments by the Novartis Venture Fund are made as equity participation typically as the lead or co-lead investor in a syndicate with a board seat.

Type
Investor
HQ
Basel, CH
Founded
1996
Novartis Venture Fund was founded in 1996 and is headquartered in Basel, CH

Key People at Novartis Venture Fund

Reza Zadno

Reza Zadno

Advisor

Novartis Venture Fund Investment Portfolio

Show more

Novartis Venture Fund News

Novartis Venture Fund Company Life